Catalyst Wire Dossier Catalyst Wire Dossier

ISIS-FGFR4RX SC

ISIS-FGFR4RX · Ionis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS-FGFR4RX SC, covering 2018-06-25 to 2018-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients [Phase 2]

See pricing